Correlation Between Jinhe Biotechnology and Northking Information

Can any of the company-specific risk be diversified away by investing in both Jinhe Biotechnology and Northking Information at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jinhe Biotechnology and Northking Information into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Jinhe Biotechnology Co and Northking Information Technology, you can compare the effects of market volatilities on Jinhe Biotechnology and Northking Information and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jinhe Biotechnology with a short position of Northking Information. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jinhe Biotechnology and Northking Information.

Diversification Opportunities for Jinhe Biotechnology and Northking Information

0.7

Correlation Coefficient

Jinhe Biotechnology  Northking Information

Poor diversification

The 3 months correlation between Jinhe and Northking is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Jinhe Biotechnology Co and Northking Information Technolo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Northking Information and Jinhe Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jinhe Biotechnology Co are associated (or correlated) with Northking Information. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Northking Information has no effect on the direction of Jinhe Biotechnology i.e., Jinhe Biotechnology and Northking Information go up and down completely randomly.

Pair Corralation between Jinhe Biotechnology and Northking Information

Assuming the 90 days trading horizon Jinhe Biotechnology is expected to generate 21.26 times less return on investment than Northking Information. But when comparing it to its historical volatility, Jinhe Biotechnology Co is 1.45 times less risky than Northking Information. It trades about 0.0 of its potential returns per unit of risk. Northking Information Technology is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,396  in Northking Information Technology on September 29, 2024 and sell it today you would earn a total of  81.00  from holding Northking Information Technology or generate 5.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Jinhe Biotechnology Co  vs.  Northking Information Technolo

Jinhe Biotechnology

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jinhe Biotechnology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Northking Information

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Northking Information Technology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Northking Information may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Jinhe Biotechnology and Northking Information

The main advantage of trading using opposite Jinhe Biotechnology and Northking Information positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jinhe Biotechnology position performs unexpectedly, Northking Information can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Northking Information will offset losses from the drop in Northking Information's long position.

The idea behind Jinhe Biotechnology Co and Northking Information Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.